Vascular Biogenics Stock Quote VBLT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.156

Bid

0.1598

Ask

0.1599

Volume

0.00 Day's Range 0.00

5.32 52 Week Range 11.20

Market Cap

66.263M

Previous Close

0.156

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,750,000

Dividend Yield

PE Ratio

-2.05

Earnings Per Share (EPS)

-0.46

Revenue

658k

Net Profit

-32.3M

Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumo... Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.vblrx.com

Headquarters

Modi'in-maccabim-re'ut, Center, Isr

Founded

1970

Vascular Biogenics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VBLT. The last closing price for Vascular Biogenics was $0.16. Over the last year, Vascular Biogenics shares have traded in a share price range of $ 5.32 to $ 11.20.

Vascular Biogenics currently has 69,750,000 shares outstanding. The market capitalization of Vascular Biogenics is $66.26 million. Vascular Biogenics has a price to earnings ratio (PE ratio) of -2.05.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	-6.0915	-97.5030012005	6.2475	11.2	5.32	1088403	8.37956178	CS
156	-65.294	-99.7616501146	65.45	106.4	3.5315	1372989	14.4529186	CS
260	-46.044	-99.6623376623	46.2	110.95	3.5315	913152	22.09832418	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PEGYPineapple Energy Inc	$ 0.0638 (39.30%)	20.63M
HWHHWH International Inc	$ 1.76 (37.50%)	525.67k
IBRXImmunityBio Inc	$ 6.55 (32.59%)	993.63k
NUWENewellis Inc	$ 0.42 (25.75%)	2.11M
AGBAAGBA Group Holding Ltd	$ 3.05 (22.00%)	1.54M
ABEOAbeona Therapeutics Inc	$ 3.90 (-47.01%)	44.18k
GWAVGreenwave Technology Solutions Inc	$ 0.0785 (-37.85%)	420.18k
TTOOT2 Biosystems Inc	$ 2.56 (-18.99%)	24.35k
HUGEFSD Pharma Inc	$ 0.4001 (-18.18%)	1
PHIOPhio Pharmaceuticals Corporation	$ 0.69 (-16.86%)	9.01k
PEGYPineapple Energy Inc	$ 0.063 (37.55%)	20.64M
NUWENewellis Inc	$ 0.42 (25.75%)	2.11M
AGBAAGBA Group Holding Ltd	$ 3.05 (22.00%)	1.54M
JAGXJaguar Health Inc	$ 0.1555 (-13.56%)	1.41M
IBRXImmunityBio Inc	$ 6.55 (32.59%)	993.63k